Assessing Synopsys (SNPS) Valuation After Recent Share Price Weakness

Why Synopsys (SNPS) is on investors’ radar now

Synopsys (SNPS) has drawn attention after shares closed at US$392.24, with recent returns showing a month decline of 9.4% and a past 3 months decline of 25.3%. This has prompted closer scrutiny of the company’s fundamentals.

See our latest analysis for Synopsys.

Beyond the latest pullback, Synopsys has faced a 25.3% 3 month share price decline and an 18.35% year to date share price decline. However, the 5 year total shareholder return of 50.42% still reflects a materially positive long run outcome.

If Synopsys’s recent weakness has you rethinking your tech exposure, this could be a useful moment to scan for other AI related opportunities through the 69 profitable AI stocks that aren't just burning cash

So with Synopsys trading at US$392.24, an intrinsic value estimate only about 2% higher, yet a much larger gap to analyst targets, should you interpret this as potential mispricing, or assume the market already incorporates expectations for future growth?

Most Popular Narrative: 27.1% Undervalued

Synopsys is trading at US$392.24, while the most followed narrative anchors on a fair value of US$537.75. This sets up a valuation gap that hinges on execution of its long term growth plan.

The accelerating complexity and proliferation of AI, high-performance computing, and multi-die/chiplet-based architectures are increasing customer demand for Synopsys' advanced design, verification, and simulation solutions, solidifying its role as a mission-critical partner in next-generation chip and system development, supporting both revenue growth and opportunities for higher-margin recurring licensing.

Read the complete narrative.

Curious what kind of revenue runway and margin profile sit behind that mission critical role, and how a premium earnings multiple fits into the story? The narrative connects ambitious growth, higher recurring revenue and a rich future P/E into one valuation case, but the exact trade offs only show up when you see the full model.

Result: Fair Value of $537.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can change quickly if China related headwinds deepen or if the large Ansys integration and IP business transition prove more costly and disruptive than expected.

Find out about the key risks to this Synopsys narrative.

Another Way To Look At Synopsys’ Valuation

The narrative leans heavily on a future P/E of 88x, but today Synopsys trades on a P/E of 68x versus 26.9x for the wider US Software group and a fair ratio of 43.1x. That is a steep premium. Is the market generously pre paying for growth, or simply overestimating it?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment clearly split between risks and rewards, this is a moment to check the data for yourself and decide where you stand quickly. To see how the full picture balances out, review the 3 key rewards and 3 important warning signs.

Ready to find your next idea?

If Synopsys has sharpened your focus on quality and price, do not stop here. Use the screener to uncover other opportunities that fit your approach.

• Target reliable cash generators by reviewing companies in the solid balance sheet and fundamentals stocks screener (41 results) that can help anchor your portfolio.
• Spot potential value opportunities early by scanning the 58 high quality undervalued stocks before the rest of the market pays attention.
• Strengthen your income stream by checking out the 11 dividend fortresses that pair higher yields with resilient business profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com